GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioStem Technologies Inc (OTCPK:BSEM) » Definitions » 3-Year EBITDA Growth Rate

BioStem Technologies (BioStem Technologies) 3-Year EBITDA Growth Rate : 0.90% (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is BioStem Technologies 3-Year EBITDA Growth Rate?

BioStem Technologies's EBITDA per Share for the three months ended in Sep. 2023 was $0.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was 0.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 29.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 25.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of BioStem Technologies was 75.50% per year. The lowest was -68.00% per year. And the median was 32.75% per year.


Competitive Comparison of BioStem Technologies's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, BioStem Technologies's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioStem Technologies's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioStem Technologies's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where BioStem Technologies's 3-Year EBITDA Growth Rate falls into.



BioStem Technologies 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


BioStem Technologies  (OTCPK:BSEM) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


BioStem Technologies 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of BioStem Technologies's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


BioStem Technologies (BioStem Technologies) Business Description

Traded in Other Exchanges
N/A
Address
2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Its proprietary approach, Local MicroEnvironment Activation, uses combinations of Small Molecules, Cytokines, and Growth Factors to activate the microenvironment within the body to create communication for repair in the tissue. The Company offers a comprehensive portfolio of high-quality brands that are trademarked and include RHEO, AEON, OROPRO, VENDAJE, VENDAJE AC, and VENDAJE OPTIC.

BioStem Technologies (BioStem Technologies) Headlines

From GuruFocus

BioStem Technologies Releases Third Quarter 2018 Shareholder Update

By GlobeNewswire GlobeNewswire 12-10-2018

BioStem Life Sciences Announces ISBT 128 Registration via ICCBBA

By Marketwired Marketwired 03-28-2020

Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions

By Stock market mentor Stock market mentor 01-24-2023